ArcticZymes Technologies ASA

OSL-AZT
Oslo Børs NYSE
Healthcare Biotechnology
Global Rank
#25859
Country Rank
#160
Market Cap
81.04 M
Price
1.59
Change (%)
2.23%
Volume
4,407

ArcticZymes Technologies ASA's latest marketcap:

81.04 M

As of 06/07/2025, ArcticZymes Technologies ASA's market capitalization has reached $81.04 M. According to our data, ArcticZymes Technologies ASA is the 25859th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 81.04 M
Revenue (ttm) 10.18 M
Net Income (ttm) 216,723.04
Shares Out 51.07 M
EPS (ttm) 0
Forward PE 111.46
Ex-Dividend Date n/a
Earnings Date 08/14/2025
Market Cap Chart
Data Updated: 06/07/2025

ArcticZymes Technologies ASA's yearly market capitalization.

ArcticZymes Technologies ASA has seen its market value drop from kr3.07 B to kr819.7 M since 2020, representing a total decrease of 73.34% and an annual compound decline rate (CAGR) of 25.76%.
Date Market Cap Change (%)
06/07/2025 kr819.7 M 18.44%
12/30/2024 kr681.29 M -68.11%
12/29/2023 kr2.14 B -41.03%
12/30/2022 kr3.62 B -23.47%
12/30/2021 kr4.73 B 54.03%
12/30/2020 kr3.07 B

Company Profile

ArcticZymes Technologies ASA was founded in 1990 in Norway. on the Oslo Børs. With 54 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.